Compare Immunovant Inc. Common Stock (IMVT) vs M&T Bank Corporation (MTB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs M&T Bank Corporation — how do they compare? Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B), while M&T Bank Corporation trades at $217.33 (market cap $31.42B). The key difference: M&T Bank Corporation is far larger — about 5× Immunovant Inc. Common Stock's market cap, and M&T Bank Corporation pays a 2.76% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and M&T Bank Corporation for 100 Days on average.
| IMVT | MTB | |
|---|---|---|
Market Cap | $6.25B | $31.42B |
Volume | 1,755,411 | 1,438,219 |
Sector | Health | Financials |
52-Week High | $44.96 | $254.09 |
52-Week Low | $17.03 | $178.63 |
Typical Hold Time | 1 Days | 100 Days |
Enterprise Value | $5.35B | $47.77B |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
M&T Bank Corporation (MTB) trades at $217.23, up 0.29% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with P/E of 11.52, net margin of 30.85%, and consistent dividend payments. Recent news highlights branch expansion and AI investments driving loan growth, while analyst consensus remains cautiously optimistic with a $258.92 price target.
MTB presents a compelling value opportunity with attractive valuation metrics and solid profitability, though technical indicators suggest near-term pressure. The bank's strategic investments in technology and expanding fee businesses support long-term growth, but investors should monitor interest rate sensitivity and competitive banking sector dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →
